These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2839905)

  • 1. Neoadjuvant mitomycin C, cisplatin, and infusion vinblastine in locally and regionally advanced non-small cell lung cancer: problems and progress from the perspective of long-term follow-up.
    Spain RC
    Semin Oncol; 1988 Jun; 15(3 Suppl 4):6-15. PubMed ID: 2839905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer.
    Ellis PA; Smith IE; Hardy JR; Nicolson MC; Talbot DC; Ashley SE; Priest K
    Br J Cancer; 1995 Feb; 71(2):366-70. PubMed ID: 7530988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The case for mitomycin in non-small cell lung cancer.
    Spain RC
    Oncology; 1993 Apr; 50 Suppl 1():35-50. PubMed ID: 8387177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
    Paccagnella A; Favaretto A; Oniga F; Festi G; Lauro S; Morabito A; Ossana L; Sartore F; DePoli F; Fiorentino MV
    Cancer; 1996 Oct; 78(8):1701-7. PubMed ID: 8859183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized phase 2 evaluation of preoperative radiation therapy and preoperative chemotherapy with mitomycin, vinblastine, and cisplatin in patients with technically unresectable stage IIIA and IIIB non-small cell cancer of the lung. LCSG 881.
    Wagner H; Lad T; Piantadosi S; Ruckdeschel JC
    Chest; 1994 Dec; 106(6 Suppl):348S-354S. PubMed ID: 7988262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgery following neoadjuvant MPV chemotherapy (mitomycin, cisplatin, vinblastine) in locally advanced (IIIa and IIIb) non-small cell lung cancer.
    Carretta A; Chiesa G; Zannini P; Villa E; Verusio C; Fumagalli F; Melloni G; Grossi A
    Eur J Cardiothorac Surg; 1994; 8(9):457-61. PubMed ID: 7811477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: implications for the design of future non-small-cell lung cancer combined modality trials.
    Pisters KM; Kris MG; Gralla RJ; Zaman MB; Heelan RT; Martini N
    J Clin Oncol; 1993 Sep; 11(9):1757-62. PubMed ID: 8394881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
    Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
    Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitomycin C, vinblastine and cisplatin combination chemotherapy in the treatment of advanced non-small cell lung cancer.
    Nomura F; Shimokata K; Saito H; Sakai S; Watanabe A; Saka H
    Cancer Chemother Pharmacol; 1987; 20(4):324-6. PubMed ID: 2826032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined regional and systemic chemotherapy for advanced and inoperable non-small cell lung cancer.
    Müller H
    Eur J Surg Oncol; 2002 Mar; 28(2):165-71. PubMed ID: 11884052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized prospective study of cisplatin and vinblastine versus cisplatin, vinblastine and mitomycin in advanced non-small cell lung cancer.
    Mylonakis N; Tsavaris N; Bacoyiannis C; Karvounis N; Kakolyris S; Karabelis A; Beer M; Kosmidis P
    Ann Oncol; 1992 Feb; 3(2):127-30. PubMed ID: 1318742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose cisplatin and mitomycin C in advanced non-small cell lung cancer: a phase II study of the Northern California Oncology Group.
    Gandara DR; Perez EA; Wold H; Caggiano V; Malec M; Ahn DK; Meyers F; Carlson RW
    Cancer Chemother Pharmacol; 1990; 27(3):243-7. PubMed ID: 2176134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I-II study of cisplatin, VP-16, MGBG, mitomycin, and vinblastine with radiation therapy for non-small-cell lung cancer.
    Christian ES; Schreeder M; Salter MM; Stephens SB; Carpenter JT; Wheeler RH
    Am J Clin Oncol; 1988 Aug; 11(4):502-5. PubMed ID: 2841845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy of non small cell lung cancer. A prospectively randomized study of cisplatin-etoposide versus cisplatin-mitomycin-vinblastine.
    Polyzos A; Tsavaris N; Veslemes M; Dardoufas K; Dosios T; Kosmas C
    J Chemother; 1997 Apr; 9(2):102-5. PubMed ID: 9176747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose cisplatin and vinblastine infusion with or without radiation therapy in patients with advanced non-small-cell lung cancer.
    Blumenreich MS; Woodcock TM; Gentile PS; Barnes GR; Jose B; Sherrill EJ; Richman SP; Epremian BE; Kubota TT; Allegra JC
    J Clin Oncol; 1987 Nov; 5(11):1725-30. PubMed ID: 2824706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consolidation biochemotherapy for patients with advanced nonsmall cell lung carcinoma responding to induction PVM (cisplatin, vinblastine, mitomycin-C) regimen. A phase II study.
    Tummarello D; Graziano F; Isidori P; Santo A; Cetto G; Fedeli A; Rossi G; Cellerino R
    Cancer; 1996 Jun; 77(11):2251-7. PubMed ID: 8635092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical study of combination chemotherapy with mitomycin C, vindesine and cisplatin (MVP therapy) in advanced non-small cell lung cancer].
    Setoguchi J; Sawada M; Onodera H; Sigeta M; Nakai M; Nakano K; Kanatsuna T; Kondoh M; Hotta T; Hayashi H
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2399-403. PubMed ID: 2546504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitomycin C, vinblastine and cis-platin. An active regimen for advanced non-small cell lung cancer.
    Giaccone G; Bagatella M; Donadio M; Bonardi GM; Testore F; Ferrati P; Ciuffreda L; Calciati A
    Br J Cancer; 1987 Oct; 56(4):475-8. PubMed ID: 2825750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer.
    Hardy JR; Noble T; Smith IE
    Br J Cancer; 1989 Nov; 60(5):764-6. PubMed ID: 2478183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of chemotherapy in advanced non-small-cell lung cancer: a randomized trial of three versus six courses of mitomycin, vinblastine, and cisplatin.
    Smith IE; O'Brien ME; Talbot DC; Nicolson MC; Mansi JL; Hickish TF; Norton A; Ashley S
    J Clin Oncol; 2001 Mar; 19(5):1336-43. PubMed ID: 11230476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.